FDA Inspection 810140 — Carter BloodCare Paris
The FDA completed an inspection of Carter BloodCare Paris on December 11, 2012 in Paris, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 11, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Paris, TX (United States)